3-Methyl-6-Nitroindazole CAS 6494-19-5 Purity >98.0% (HPLC)

Short Description:

Chemical Name: 3-Methyl-6-Nitroindazole

CAS: 6494-19-5

Purity: >98.0% (HPLC)

Light Yellow to Dark Yellow to Brown Powder to Crystal

High Quality, Commercial Production

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading supplier of 3-Methyl-6-Nitroindazole (CAS: 6494-19-5) with high quality. We can provide COA, worldwide delivery, small and bulk quantities available. If you are interested in this product, please send detailed information includes CAS number, product name, quantity to us. Please contact: alvin@ruifuchem.com

Chemical Properties:

Chemical Name	3-Methyl-6-Nitroindazole
Synonyms	3-Methyl-6-Nitro-1H-Indozole; 6-Nitro-3-Methylindazole
CAS Number	6494-19-5
CAT Number	RF2682
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C8H7N3O2
Molecular Weight	177.16
Melting Point	184.0 to 188.0℃
Boiling Point	384.9±22.0℃
Density	1.437
Solubility	Chloroform (Slightly), Methanol (Slightly)
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	Light Yellow to Dark Yellow to Brown Powder to Crystal
Purity / Analysis Method	>98.0% (HPLC)
Melting Point	184.0 to 188.0℃
Loss on Drying	<1.00%
Total Impurities	<2.00%
Infrared Spectrum	Conforms to Structure
Proton NMR Spectrum	Conforms to Structure
Test Standard	Enterprise Standard
Usage	Pharmaceutical Intermediate; Pazopanib Hydrochloride Intermediate

Package & Storage:

Package: Bottle, Aluminum foil bag, 25kg/Cardboard Drum, or according to customer's requirement

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture

Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

FAQ:

How to Purchase? Please contact: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Russia, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality Assurance? Strict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

Samples? Most products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory Audit? Factory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

Transportation? By Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom Synthesis? Can provide custom synthesis services to best fit your research needs.

Payment Terms? Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Application:

3-Methyl-6-Nitroindazole (CAS: 6494-19-5) is used as Pharmaceutical Intermediate. It can be used as an intermediate of Pazopanib Hydrochloride (CAS: 635702-64-6). Pazopanib Hydrochloride is researched and developed by a GlaxoSmithKline, it is a novel oral vascular generation inhibitor which may interfere stubborn tumor survival and new blood vessels generation growth needed. Targeting vascular endothelial growth factor receptor (VEGFR), it works by inhibiting angiogenesis of tumor blood supply. It is suitable for advanced renal cell carcinoma (a discovery of cancer cells in the renal tubules), soft tissue sarcoma (STS), epithelial ovarian cancer and non-small cell lung cancer (NSCLC) treatment. The US Food and Drug Administration (FDA) approved on October 19, 2009 that Pazopanib Hydrochloride (trade name Votrient) is listed ,the sixth approved drug treatment of kidney cancer since 2005.